Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Vicore Pharma Holding AB

Closing information (x1000 EUR)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 32 More Arrow 43 More Arrow 251
Earnings before taxes -28,057 More Arrow -25,952 Less Arrow -29,015
EBITDA -28,672 More Arrow -25,823 Less Arrow -28,476
Total assets 44,866 Less Arrow 30,374 More Arrow 44,116
Current assets 44,664 Less Arrow 24,244 More Arrow 36,955
Current liabilities 3,495 More Arrow 4,160 More Arrow 6,412
Equity capital 41,041 Less Arrow 25,977 More Arrow 37,481
- share capital 5,034 Less Arrow 3,677 Less Arrow 3,508
Employees (average) 25 Less Arrow 21 Less Arrow 16

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 91.5% Less Arrow 85.5% Less Arrow 85.0%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -62.5% Less Arrow -85.3% More Arrow -65.2%
Current ratio 1277.9% Less Arrow 582.8% Less Arrow 576.3%
Return on equity (ROE) -68.4% Less Arrow -99.9% More Arrow -77.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 4 More Arrow 5 Less Arrow 3
Chg. No. of employees % 19% More Arrow 31% Less Arrow 23%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.